BSI-201
BSI-201 is a PARP1 inhibitor with demonstrated effectiveness in triple-negative breast cancer (TNBC).
Trivial name | NSC-746045; IND 71677; Iniparib |
Catalog Number | CSN12304 |
Alternative Name(s) | NSC-746045; IND 71677; Iniparib |
Research Area | Cancer |
Molecular Formula | C7H5IN2O3 |
CAS# | 160003-66-7 |
Purity | ≥97% |
SMILES | IC1=C(C=C(C(=O)N)C=C1)[N+](=O)[O-] |
Size | 50mg |
Supplier Page | https://www.csnpharm.com/products/bsi-201.html |